iDigiPath Solutions
↗Kochi, India
iDigiPath Solutions is an early-stage biotechnology and digital health company specializing in digital pathology. Incorporated in August 2025, the company aims to transform traditional pathology workflows by leveraging artificial intelligence, cloud-based image analysis, and digital imaging technologies to improve diagnostic precision and efficiency.
The company is part of the emerging biotech ecosystem in Kerala, India, and is registered with the Biotechnology Industry Research Assistance Council (BIRAC). It appears to be a strategic expansion or spin-off involving leadership from 64 Codon, a genomics and bioinformatics firm, suggesting a strong foundation in computational biology and diagnostic data analysis.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Digital Pathology & AI Diagnostics
SIZE & FINANCIALS
Employees:1-50
Revenue:<$1M
Founded:2025
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Founders, BIRAC (Grant/Registration support)
PIPELINE
Stage:Discovery
Lead Drug Stage:Software Development/Beta
Modalities:AI-driven software, Digital Imaging, Cloud Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:BIRAC (Biotechnology Industry Research Assistance Council), 64 Codon Private Limited (Affiliated entity)
COMPETITION
Position:Emerging
Competitors:PathAI, Paige.ai, Proscia, SigTuple
LEADERSHIP
Key Executives:
Subramanian Jayaram - Director & Founder
Indumathi Jayaram - Director
Anuradha Subramanian - Director
Scientific Founders:Subramanian Jayaram
Board Members:Subramanian Jayaram, Indumathi Jayaram, Anuradha Subramanian
LINKS
Website:idigipath.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with iDigiPath Solutions. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.